Dana Drugs showcases products at 81st Annual PSN Conference

27th October 2008

Dana Drugs Limited, one of Nigeria’s foremost pharmaceutical companies, has announced that it will showcase its products at the 81st Annual National Conference of the Pharmaceutical Society of Nigeria (PSN) holding at the International Conference Centre, Abuja from the 3rd to the 7th of November 2008.

Tagged ‘Positioning pharmacy practice towards achieving Vision 2020’, the conference will see seasoned professionals from various areas of pharmacy practice come together to address issues affecting the industry, with the ultimate goal of safe guarding and improving the health of Nigerians, thus facilitating the realization of the country’s developmental goals.

Speaking on his company’s participation at the conference, Mr. Prasenjit Banerji, General Manager, Dana Drugs said, “The objective of the Pharmaceutical Society Nigeria matches Dana Drugs vision of providing Nigerians with quality healthcare products. A conference such as this provides us with the opportunity to interact with our professional colleagues and appreciate our collective efforts at ensuring that Nigeria achieves reasonable self-sufficiency in local drugs production. We will be proudly showcasing the full range of products that Dana Drugs is reputed for at the event.”

The 5-day conference will be declared open by His Excellency, Dr. Yakubu Gowon, former Head of State, Federal Republic of Nigeria. It will feature the exhibition of healthcare products made by indigenous Nigerian companies. Pharmaceuticals giants such as GlaxoSmithKline, May and Baker, Dana Drugs, Evans Medical Plc and Fidson Healthcare Limited amongst others are expected to showcase their products at the event.

The Pharmacy Society of Nigeria (PSN) is the country’s foremost association of pharmacists. The body is committed to the development of Nigeria by promoting good healthcare system. The PSN has always maintained that the solution to the chaotic drug distribution largely depends on the total eradication and permanent dismantling of all structures that encourage the sale of drugs in open markets.

Dana Drugs Limited is a subsidiary of Dana Group, an industrial and commercial conglomerate with interest in automobile, aviation, steel, electronics, food packaging, plastics and chemicals.